Link to the press release on the Alzheimer's Association's website.
CHICAGO, February 1, 2022 — The Alzheimer's Association Dementia Care Provider Roundtable (AADCPR) awarded a partial sponsorship of $150,000 to Amanda Leggett, Ph.D., of the University of Michigan to fund her research focusing on improving the lives of family caregivers and individuals living with dementia.
The sponsorship and grant support Leggett's work measuring and classifying different styles of caregiving and how they affect health outcomes for both individuals with dementia and their caregivers.
"Our goal is to individualize treatment recommendations and interventions for caregivers, potentially leading to lower levels of care-related stress and a better quality of life for both members of the care partnership," said Leggett. "I am grateful to the Alzheimer’s Association Dementia Care Provider Roundtable for their commitment to this important work."
This sponsorship is part of the $242,056 awarded to Leggett through the Association’s Advancing Research on Care and Outcome Measurements (ARCOM) grant program, which supports psychosocial research that aims to improve dementia care.
Launched in 2018, the AADCPR represents a consortium of thought leaders from the dementia care provider industry working to advance care and support services for people with dementia and their caregivers, including through the dissemination and adoption of evidence-based Alzheimer's Association Dementia Care Practice Recommendations. The group is composed of 23 organizations representing home health, home care, life plan communities, assisted living and nursing homes.
"The Roundtable members are committed to advancing our knowledge and improving care for people living with Alzheimer's and other dementias across care settings," said Lakelyn Hogan, Ph.D., chair of the AADCPR. "We're proud to support research that aims to achieve better care and outcomes for both people living with dementia and their caregivers."
Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.
